We are the second largest university hospital in Norway. The investment in medical and health-related research and innovation is extensive. We have several cutting-edge research environments at a high international level, at the same time we believe that it is important to have breadth in research.
As a regional hospital with many specific functions and high competence, we have particular responsibility for conducting research-based patient treatment, education and training of health personnel.
Interested in research cooperation?
Clinical Trial Unit
The Clinical Trial Unit at Haukeland University Hospital has broad experience and advanced facilities for early clinical trials for both adults and children, and a high quality laboratory facility for handling of chemical and biological material including living cells.
National research support network
Haukeland University Hospital is a partner in the national research support network NorCRIN. The local NorCRIN contact point supports researchers with administrative procedures, quality control and study monitoring around clinical trials. The national network can be used to facilitate national multi-center studies. As an ECRIN member, NorCRIN can facilitate research support on a European level.
HUH as a partner in your collaborative research project?
Haukeland University Hospital has first class research environment and research groups active in many international projects, especially Horizon 2020 and NIH. We can help you get in contact with relevant researchers, contact the Grants Office: firstname.lastname@example.org
Are you a (post)doctoral researcher interested in Marie Curie Individual Fellowships (MSCA IF)? These fellowships are for researchers wanting to work abroad and thus enhance their career prospects. Haukeland University Hospital, as your host institution, allows you to work in a first class research environment while benefitting from an attractive remuneration package. The Grants Office can help you with finding a supervisor, invite you to a MSCA IF application writing workshop in Bergen and support you throughout the application process.
Contact the Grants Office: email@example.com
Research and innovation
Despite decreases in mortality rates and improved treatment methods, 450,000 Norwegians live with chronic cardiovascular conditions that not only affect their daily life but also have implications for clinicians, healthcare systems and society at large. Patient-reported outcomes, together with clinical outcome measures, form the foundation for shared decision-making and are of special importance in cardiovascular clinical practice.
- Dried plasma
Helse Bergen has received 15 millions in funding from Innovation Norway to develop technology for local production of dried plasma. This technology is of interest both on an national and international level.
- Regenerative Medicine
In Mohn Research Centre for Regenerative Medicine (MRCRM), we aim to develop new cell-based therapies to repair or replace - to regenerate - tissues and cells damaged by disease or injury. Our research focus spans from biomedical to clinica...